In vivo experiments observed that these cells (CAR-T/IL-15/IlL-21) showed a larger expansion and persistence, resulting in greater control of tumor burden and survival of animals when compared to only CAR-T cells and CAR-T cells with the secretion of isolated cytokines. This evidence concerns the gene IL15 and neoplasm.